Skip to main content
Caitlin (Sanstead) Zebley, MD, Pediatric Hematology & Oncology, Memphis, TN

Caitlin (Sanstead) Zebley MD PhD


Physician

Join to View Full Profile
  • 262 Danny Thomas PlMemphis, TN 38105

  • Phone+1 901-595-3300

Dr. Zebley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 2012 - 2015
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2012
  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology
  • St. Jude Graduate School of Biomedical Sciences
    St. Jude Graduate School of Biomedical Sciences PhD, Immunology

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2016 - 2026
  • MN State Medical License
    MN State Medical License 2013 - 2016
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia
    Caitlin Zebley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Disruption of Asxl1 Gene Improves Tumor Control in Immunotherapy
    Disruption of Asxl1 Gene Improves Tumor Control in ImmunotherapyOctober 11th, 2024
  • Disrupting Asxl1 Gene Prevents T-cell Exhaustion, Improving Immunotherapy
    Disrupting Asxl1 Gene Prevents T-cell Exhaustion, Improving ImmunotherapyOctober 10th, 2024
  • Ava's Army Supports Alex's Lemonade Stand Foundation in Funding High-Impact Research in Pediatric Leukemia
    Ava's Army Supports Alex's Lemonade Stand Foundation in Funding High-Impact Research in Pediatric LeukemiaMarch 22nd, 2022
  • Join now to see all

Grant Support

  • Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth”ST. JUDE CHILDREN'S RESEARCH HOSPITAL2023–2028

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: